Skip to content
  • Resources for clinicians
  • Resources for people with hearing loss
  • Careers
  • Media
    • Latest News
    • Media Package
  • Investor Relations
  • Contact
Rinri Therapeutics
  • This is Rinri
    • Our Company
    • Our Team
    • Latest News
  • Our Therapy Area
    • Overview
    • Facts, Figures and Statistics
    • The perspective of people with hearing loss
  • Our Technology
    • Overview
    • Discovery
    • From Laboratory to Patients
    • Journey to the Centre of the Cochlea
    • Clinical Trials
  • This is Rinri
    • Our Company
    • Our Team
    • Latest News
  • Our Therapy Area
    • Overview
    • Facts, Figures and Statistics
    • The perspective of people with hearing loss
  • Our Technology
    • Overview
    • Discovery
    • From Laboratory to Patients
    • Journey to the Centre of the Cochlea
    • Clinical Trials
  • Resources for Clinicians
  • Resources for Patients
  • Careers
  • Media
    • Latest News
    • Media Package
  • Investor Relations
  • Contact
Rinri Therapeutics
  • This is Rinri
    • Our Company
    • Our Team
    • Latest News
  • Our Therapy Area
    • Overview
    • Facts, Figures and Statistics
    • The perspective of people with hearing loss
  • Our Technology
    • Overview
    • Discovery
    • From Laboratory to Patients
    • Journey to the Centre of the Cochlea
    • Clinical Trials
  • Resources for Clinicians
  • Resources for Patients
  • Careers
  • Media
    • Latest News
    • Media Package
  • Investor Relations
  • Contact
Rinri Therapeutics
  • This is Rinri
    • Our Company
    • Our Team
    • Latest News
  • Our Therapy Area
    • Overview
    • Facts, Figures and Statistics
    • The perspective of people with hearing loss
  • Our Technology
    • Overview
    • Discovery
    • From Laboratory to Patients
    • Journey to the Centre of the Cochlea
    • Clinical Trials
  • Resources for Clinicians
  • Resources for Patients
  • Careers
  • Media
    • Latest News
    • Media Package
  • Investor Relations
  • Contact

Slide

tabs

  • Executive Committee

  • Scientific Committee

  • Advisory Board

  • Executive Committee

Professor Marcelo Rivolta

Professor Marcelo Rivolta

Founder and Chief Scientific Officer

Marcelo is a globally recognised Professor of Sensory Stem Cell Biology. He has been based at Sheffield University in the UK since 2001 and has written over 40 papers on the subject, many of which have been published in peer-review journals. The Rivolta Laboratory, which he established at Sheffield University, is dedicated to studying the biology and behaviour of auditory stem cells, and to exploring their potential to regenerate the damaged inner ear.

Read more
Simon Chandler

Dr. Simon Chandler

Chief Executive Officer

Simon is CEO of Rinri Therapeutics, responsible for the strategic direction and operation of the company. He has been involved since its inception and works closely with Marcelo Rivolta, Rinri’s founder.

Read more

Dr. Terri Gaskell

Chief Operating Officer

Terri has over 20 years of research and development experience within life sciences, in both academic and industry roles, with a focus on the development and translation of cell and gene-based therapies.

Read more

Professor Doug Hartley

Chief Medical Officer

Doug is a Professor of Otology at Nottingham University and a consultant ENT surgeon at Nottingham University Hospital’s NHS Trust – Queen’s Medical Centre. He qualified, with distinction, from Newcastle Medical School in 1995, and was awarded a DPhil from Oxford University in the field of hearing research in 2001.

Read more

Rachel Haines

Director of Clinical Operations

Rachel Haines joined Rinri Therapeutics as Director of Clinical Operations in October 2022. She is a hearing scientist by training and has worked in translational research and clinical trials within both the domestic and international markets and public and private sectors since 2007.

Read more

Dr. Faizah Mushtaq

Clinical Director

Faizah is a clinically qualified audiologist who has previously provided hearing care to patients within both NHS and private settings. Subsequent completion of an MSc in Cognitive Neuroscience facilitated her transition from a clinician into a researcher and prepared her with the skills required to study for a doctorate (PhD) in translational hearing research.

Read more
  • Scientific Committee

Professor Marcelo Rivolta

Professor Marcelo Rivolta

Founder and Chief Scientific Officer

Marcelo is a globally recognised Professor of Sensory Stem Cell Biology. He has been based at Sheffield University in the UK since 2001 and has written over 40 papers on the subject, many of which have been published in peer-review journals. The Rivolta Laboratory, which he established at Sheffield University, is dedicated to studying the biology and behaviour of auditory stem cells, and to exploring their potential to regenerate the damaged inner ear.

Read more
Simon Chandler

Dr. Simon Chandler

Chief Executive Officer

Simon is CEO of Rinri Therapeutics, responsible for the strategic direction and operation of the company. He has been involved since its inception and works closely with Marcelo Rivolta, Rinri’s founder.

Read more

Dr. Terri Gaskell

Chief Operating Officer

Terri has over 20 years of research and development experience within life sciences, in both academic and industry roles, with a focus on the development and translation of cell and gene-based therapies.

Read more

Professor Doug Hartley

Chief Medical Officer

Doug is a Professor of Otology at Nottingham University and a consultant ENT surgeon at Nottingham University Hospital’s NHS Trust – Queen’s Medical Centre. He qualified, with distinction, from Newcastle Medical School in 1995, and was awarded a DPhil from Oxford University in the field of hearing research in 2001.

Read more

Rachel Haines

Director of Clinical Operations

Rachel Haines joined Rinri Therapeutics as Director of Clinical Operations in October 2022. She is a hearing scientist by training and has worked in translational research and clinical trials within both the domestic and international markets and public and private sectors since 2007.

Read more

Dr. Faizah Mushtaq

Clinical Director

Faizah is a clinically qualified audiologist who has previously provided hearing care to patients within both NHS and private settings. Subsequent completion of an MSc in Cognitive Neuroscience facilitated her transition from a clinician into a researcher and prepared her with the skills required to study for a doctorate (PhD) in translational hearing research.

Read more
  • Advisory Board

Professor Marcelo Rivolta

Professor Marcelo Rivolta

Founder and Chief Scientific Officer

Marcelo is a globally recognised Professor of Sensory Stem Cell Biology. He has been based at Sheffield University in the UK since 2001 and has written over 40 papers on the subject, many of which have been published in peer-review journals. The Rivolta Laboratory, which he established at Sheffield University, is dedicated to studying the biology and behaviour of auditory stem cells, and to exploring their potential to regenerate the damaged inner ear.

Read more
Simon Chandler

Dr. Simon Chandler

Chief Executive Officer

Simon is CEO of Rinri Therapeutics, responsible for the strategic direction and operation of the company. He has been involved since its inception and works closely with Marcelo Rivolta, Rinri’s founder.

Read more

Dr. Terri Gaskell

Chief Operating Officer

Terri has over 20 years of research and development experience within life sciences, in both academic and industry roles, with a focus on the development and translation of cell and gene-based therapies.

Read more

Professor Doug Hartley

Chief Medical Officer

Doug is a Professor of Otology at Nottingham University and a consultant ENT surgeon at Nottingham University Hospital’s NHS Trust – Queen’s Medical Centre. He qualified, with distinction, from Newcastle Medical School in 1995, and was awarded a DPhil from Oxford University in the field of hearing research in 2001.

Read more

Rachel Haines

Director of Clinical Operations

Rachel Haines joined Rinri Therapeutics as Director of Clinical Operations in October 2022. She is a hearing scientist by training and has worked in translational research and clinical trials within both the domestic and international markets and public and private sectors since 2007.

Read more

Dr. Faizah Mushtaq

Clinical Director

Faizah is a clinically qualified audiologist who has previously provided hearing care to patients within both NHS and private settings. Subsequent completion of an MSc in Cognitive Neuroscience facilitated her transition from a clinician into a researcher and prepared her with the skills required to study for a doctorate (PhD) in translational hearing research.

Read more
rinri-therapeutics2022-11-09T16:45:37+00:00

Get in touch

Thank you for your message. It has been sent.
There was an error trying to send your message. Please try again later.

Rinri Therapeutics Ltd.
Innovation Centre
217 Portobello
Sheffield S1 4DP

Tel. +44 [0] 114 222 4330
Email. enquiries@rinri-therapeutics.com

Legal

Terms and Conditions
Privacy Policy
Cookie Policy

© Rinri Therapeutics Ltd. All Rights Reserved. Registered number 08839972

Page load link
Go to Top